F&P myAirvo 3 Advanced Humidified High-Flow Therapy

The F&P myAirvo 3 System provides humidified high flow therapy for patients at home and in long-term care facilities.

F&P myAirvo 3: Advanced Humidified High-Flow Therapy for Home Respiratory Care

The F&P myAirvo 3 sets a new standard in humidified high-flow therapy. It delivers supportive respiratory care for patients in their homes and long-term care settings. This advanced system offers intuitive operation, reliable performance, and a wide range of compatible accessories. Its innovative technology helps patients breathe comfortably while maintaining consistent therapy.

Enhanced Humidified High-Flow Therapy

The device enables warm, humidified flow therapy designed to support stable breathing. It blends high-quality airflow with precise humidity control. This creates a comfortable experience for users with long-term respiratory conditions. The streamlined setup helps patients begin treatment quickly. It also encourages ongoing compliance through an easy-to-manage interface.

The system includes a large touch-screen display that shows therapy settings, alarms, and live information. This ensures users can access essential data instantly. The screen improves usability and reduces confusion during daily operation.

Integrated Remote Monitoring for Better Care

The F&P myAirvo 3 supports F&P InfoSmart Web, a cloud-based monitoring platform. Healthcare professionals can track therapy progress remotely. They can also review patient-reported symptoms over time. This improves early intervention, which can be important for long-term outcomes. Remote visibility also helps clinicians understand usage patterns. These insights support improved therapy adjustments and personalized care.

The system can upload therapy data automatically through the InfoUSB. This makes data transfer simple. It also supports more accurate clinical review.

Reliable Power Options for Continuous Therapy

A common concern for many patients is interrupted treatment. The optional integrated battery protects against power outages. This feature gives users confidence that their therapy will continue without disruption. The battery offers strong performance and convenient recharge capability. It is ideal for patients living in areas with unstable electricity supply.

Comfort-Focused Interface Options

Patients can choose from a wide range of Optiflow+ interfaces to suit their comfort needs. These include nasal cannulas, mask adapters, and tracheostomy connections. The Optiflow+ Duet nasal cannula features an asymmetric prong design that supports quieter therapy and improved CO₂ clearance. Its design reduces dead-space rebreathing and enhances humidified flow delivery. The interface options support pediatric and adult users, making the system suitable for diverse patient needs.

Accessories and Consumables for Long-Term Use

The myAirvo 3 works with standardiaed accessories that simplify maintenance. Patients can choose from the ** reusable chamber** or Auto-fill Chamber Kit. The AirSpiral tube improves humidity retention and reduces condensate. The system also supports water bags, optional oximeters, and high-quality air filters. Each accessory offers recommended use timelines to help maintain optimal performance.

Consumables such as cannulas, chambers, and filters are easy to replace. This helps maintain safe and efficient therapy over the long term. The system’s design promotes regular upkeep without creating a burden for users or caregivers.

Optimiaed Usability for Home and Facility Care

The F&P myAirvo 3 was created with ease of use in mind. Its simple controls allow patients to adjust their therapy without confusion. The touch screen guides users through alarms and notifications. Therapy information remains clear and accessible. The device also works well on a mobile pole stand, enabling flexible placement in different care environments.

The patient symptom questionnaire helps track wellbeing over time. With preset questions, patients can report changes quickly. Clinicians then use this data to evaluate progress and modify treatment plans as needed.

A Complete Solution for Long-Term Respiratory Support

The F&P myAirvo 3 combines advanced technology with patient-friendly features. It helps individuals manage chronic respiratory conditions more comfortably at home. Its integrated monitoring, high-quality humidification, and accessory range make it a dependable option. With a focus on comfort and safety, the device enhances both daily therapy and long-term care.

The combination of humidified high-flow therapy, intelligent monitoring, and innovative interface design positions the myAirvo 3 as a leading solution in respiratory support. It supports both patient independence and clinical oversight. This balance offers lasting value for home-care environments.

myAirvo 3 resources

myAirvo 3 Product Brochure

myAirvo 3 Use and Care Guide

Integrated remote monitoring
Patient symptom questionnaire
SpO₂ monitoring
Large touch screen display
Battery for power security

Fisher & Paykel Healthcare standard 2-year product warranty

Speicifications General

Dimensions	205 mm x 295 mm x 190 mm (8.0” x 11.7” x 7.5”)
Weight	device only 4.45 kg (9.8 lb.)
Supply voltage/current	100 – 115 VAC, 2.4 A (2.6 A max¹) 220 – 240 VAC, 1.1 A (1.3 A max¹)
Supply frequency	50 – 60 Hz
USB port sourcing (1 and 2)	5 V, 0.25 A (maximum each port)
Sound level	< 50 dBA @ 1 m
Auditory alarm	Sound pressure level > 40 dBA @ 1m Mute duration 120 s duration
Ingress protection	IP22²
Expected service life	5 years³

Operating conditions

Ambient temperature	18 – 28 °C (64 – 82 °F)
Humidity	10 – 95% relative humidity (non-condensing)
Ambient pressure	700 - 1060 hPa
Altitude	0 - 3000 m (9840 ft)
Mode of operation	Continuous operation
Maximum delivered dew-point temperature of respiratory gas	43 °C (109 °F)
Maximum surface temperature of applied parts⁴	44 °C (111 °F)
Maximum water chamber liquid volume	Reusable Chamber 560 mL Auto-fill Chamber 100mL Water Bag 1000mL

Storage and transport conditions

Operating, transporting or storing the device outside the permissible environment conditions specified may result in degraded performance.
Ambient temperature^5,6	-10 – 50 °C (14 – 122 °F)
Humidity (non-condensing)	10 – 95% relative humidity

Optional battery (900PT957L)

Chemistry	Lithium Ion (Li-Ion)
Voltage	14.4 VDC
Capacity	≤ 99.4 Wh
Power output	80 W
Battery life	300 charge/discharge cycles or 2 years from first use (whichever comes first)
Recharge time	6 hours (max.)
Shelf life	3 years
Operating time⁷	Typical 60 minutes Worst case⁸ 30 minutes

Communications

Cellular modem⁹	Depending on device model and market, any of the following frequency bands may be applicable.
UMTS 3G	B1, B5, B8 Max. power 24 dBm +1 / -3
LTE Cat-M	B1, B2, B3, B4, B5, B8, B12, B13, B14, B17, B18, B19, B20, B25, B26, B27, B28, B66 Max. power 23 dBm ± 1.5
LTE Cat-1	B3, B5, B8, B28 Max. power 23 dBm ± 2

Supplementary oxygen

Maximum flow rate	15 L/min oxygen (STPD¹⁰)

Oxygen sensor

Startup time	< 30 s
Response time	< 60 s
Range	21 - 100% O₂

Optiflow high flow therapy¹¹

Target humidity range	31 – 37 °C (88 - 98.6 °F)
Target flow range¹²	2 - 60 L/min
Maximum limited pressure¹³	60 cmH₂O
Maximum operating pressure	< 45 cmH₂0
Humidity⁴	Wall-power > 33 mg/L @ 37 °C target humidity, 10-60L/min target flow > 16mg/L for all other settings
Static temperature stability	± 2 °C
Warm up time¹⁴ (Auto-fill Chamber)	23 ± 2 °C to 37 °C (73 ± 3.6°F to 88 °F) < 20 minutes @ 60 L/min flow rate
Warm up time¹⁴ (Reusable Chamber)	23 ± 2 °C to 37 °C (73 ± 3.6°F to 98.6 °F) < 40 minutes @ 60 L/min flow rate

Notes:

Inrush current may reach 50 A.
The device is protected against harmful effects of dripping water when tilted by up to 15° and/or incursion of fingers or similar sized objects.
Assumes typical usage pattern. Actual service life may vary.
In accordance with ISO 80601-2-74. Tested to an accuracy of ± 1 °C or ± 1 mg/L as appropriate.
Storage at temperatures above 40 °C (104 °F) for prolonged periods will accelerate battery degradation.
The device may require up to 24 hours to equilibrate to operating temperature before it is ready for use.
Length of time flow and oxygen will be delivered. Reduced level of humidification while running on battery power.
Worst-case operating time applies to a fully charged battery at 25 °C that has experienced 300 charge/discharge cycles followed by 3 years of storage.
Country and carrier dependent.
Flow rate is expressed in STPD (standard temperature and pressure, dry) as per ISO 80601-2-74.
Values are expressed in BTPS (body temperature, pressure, saturated) unless otherwise stated.
Maximum achievable flow rate depends on the patient interface selected.
In accordance with ISO 80601-2-90.
Applies when the device is connected to a wall power supply for warm up.